George Sellers
Stock Analyst at Stephens & Co.
(1.04)
# 3,895
Out of 5,135 analysts
44
Total ratings
26.47%
Success rate
-7.01%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Maintains: Overweight | $115 → $145 | $121.00 | +19.83% | 5 | Jan 2, 2026 | |
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $76.23 | -10.80% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $112.51 | +157.75% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $37.44 | +54.91% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $135.50 | +31.37% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $10.52 | +128.14% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $22.07 | +226.23% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.92 | +27.55% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $1.85 | +1,251.35% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $17.56 | +224.60% | 6 | Aug 14, 2023 |
Glaukos
Jan 2, 2026
Maintains: Overweight
Price Target: $115 → $145
Current: $121.00
Upside: +19.83%
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $76.23
Upside: -10.80%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $112.51
Upside: +157.75%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $37.44
Upside: +54.91%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $135.50
Upside: +31.37%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $10.52
Upside: +128.14%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $22.07
Upside: +226.23%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.92
Upside: +27.55%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $1.85
Upside: +1,251.35%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $17.56
Upside: +224.60%